These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28928267)

  • 1. Impact of type I Boston keratoprosthesis implantation on vision-related quality of life.
    Ang M; Man R; Fenwick E; Lamoureux E; Wilkins M
    Br J Ophthalmol; 2018 Jul; 102(7):878-881. PubMed ID: 28928267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vision-related quality-of-life assessment using NEI VFQ-25 in patients after Boston keratoprosthesis implantation.
    Cortina MS; Hallak JA
    Cornea; 2015 Feb; 34(2):160-4. PubMed ID: 25411934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Uniocular Visual Acuity Substantially Underestimates the Impact of Visual Impairment on Quality of Life Compared with Binocular Visual Acuity.
    Kidd Man RE; Liang Gan AT; Fenwick EK; Thakur S; Gupta P; Teo ZL; Cheng CY; Wong TY; Lamoureux EL
    Ophthalmology; 2020 Sep; 127(9):1145-1151. PubMed ID: 32222400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Boston Keratoprosthesis in severe ocular trauma.
    Harissi-Dagher M; Dohlman CH
    Can J Ophthalmol; 2008 Apr; 43(2):165-9. PubMed ID: 18347618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of visual outcomes following Boston type 1 keratoprosthesis implantation.
    Ahmad S; Akpek EK; Gehlbach PL; Dunlap K; Ramulu PY
    Am J Ophthalmol; 2015 Apr; 159(4):739-47. PubMed ID: 25555801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes After Comprehensive Vision Rehabilitation Using Vision-related Quality of Life Questionnaires: Impact of Vision Impairment and National Eye Institute Visual Functioning Questionnaire.
    Selivanova A; Fenwick E; Man R; Seiple W; Jackson ML
    Optom Vis Sci; 2019 Feb; 96(2):87-94. PubMed ID: 30589760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
    Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
    Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency.
    Aravena C; Bozkurt TK; Yu F; Aldave AJ
    Cornea; 2016 Sep; 35(9):1156-64. PubMed ID: 27387566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate-Term and Long-Term Outcomes With the Boston Type 1 Keratoprosthesis in Aniridia.
    Shah KJ; Cheung AY; Holland EJ
    Cornea; 2018 Jan; 37(1):11-14. PubMed ID: 28990998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of bilateral sequential implantation of the Boston keratoprosthesis type 1.
    Vaillancourt L; Papanagnu E; Elfekhfakh M; Fadous R; Harissi-Dagher M
    Can J Ophthalmol; 2017 Feb; 52(1):80-84. PubMed ID: 28237154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
    Robert MC; Biernacki K; Harissi-Dagher M
    Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vision-Related Quality of Life in Keratoconus: A Save Sight Keratoconus Registry Study.
    Tan JCK; Nguyen V; Fenwick E; Ferdi A; Dinh A; Watson SL
    Cornea; 2019 May; 38(5):600-604. PubMed ID: 30730335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of anti-vascular endothelial growth factor treatment on quality of life in neovascular age-related macular degeneration.
    Finger RP; Guymer RH; Gillies MC; Keeffe JE
    Ophthalmology; 2014 Jun; 121(6):1246-51. PubMed ID: 24518613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Results of the Boston Keratoprosthesis for Unilateral Corneal Disease.
    Kosker M; Suri K; Rapuano CJ; Ayres BD; Nagra PK; Raber IM; Hammersmith KM
    Cornea; 2015 Sep; 34(9):1057-62. PubMed ID: 26114818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.
    Fadous R; Levallois-Gignac S; Vaillancourt L; Robert MC; Harissi-Dagher M
    Br J Ophthalmol; 2015 Dec; 99(12):1664-8. PubMed ID: 26034079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a low-cost design keratoprosthesis in end-stage corneal disease: a preliminary study.
    Sharma N; Falera R; Arora T; Agarwal T; Bandivadekar P; Vajpayee RB
    Br J Ophthalmol; 2016 Mar; 100(3):323-7. PubMed ID: 26271267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in vision-related quality of life and influencing factors in Asians receiving treatment for neovascular age-related macular degeneration.
    Fenwick EK; Cheung GCM; Gan AT; Tan G; Lee SY; Wong D; Yeo I; Mathur R; Wong TY; Lamoureux EL
    Br J Ophthalmol; 2018 Mar; 102(3):377-382. PubMed ID: 28659392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boston type 1 keratoprosthesis: the CHUM experience.
    Robert MC; Harissi-Dagher M
    Can J Ophthalmol; 2011 Apr; 46(2):164-8. PubMed ID: 21708085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.